CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teva Pharmaceutical Industries Ltd. v. Torrent Pharmaceuticals Ltd.

1:07-cv-00024

Overview

Case Number 1:07-cv-00024
Filing Date 2007-01-12
Status Terminated
Termination Date 2007-02-15
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1338 Patent Infringement
Jury Demand None

Parties

Defendant

Torrent Pharma Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Torrent Pharmaceuticals Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Teva Pharmaceuticals U.S.A., Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6600073
Methods for preparation of sertraline hydrochloride polymorphs
Filed: 2000-06-05
Issued: 2003-07-29
Expired (Term Ended)
Expires: 2020-06-05
US6500987
Sertraline hydrochloride polymorphs
Filed: 1999-11-24
Issued: 2002-12-31
Expired (Term Ended)
Expires: 2019-11-24
US6495721
Sertraline hydrochloride Form II and methods for the preparation thereof
Filed: 2000-05-22
Issued: 2002-12-17
Expired (Term Ended)
Expires: 2020-05-22
US6897340
Processes for preparation of polymorphic form II of sertraline hydrochloride
Filed: 2003-04-29
Issued: 2005-05-24
Expired (Term Ended)
Expires: 2023-04-29

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(13 total)
Pleading / Complaint

COMPLAINT filed against Torrent Pharmaceuticals Ltd., Torrent Pharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 146022.) - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Exhibit D# 5 Civil Cover Sheet # 6 Acknowledgement of Consent Form)(els) (Entered: 01/16/2007)

Entry #1 • 2007-01-12
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (els) (Entered: 01/16/2007)

Entry #2 • 2007-01-12
1

Disclosure Statement pursuant to Rule 7.1 filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals U.S.A., Inc. identifying Orvet UK Ltd., Teva Pharmaceuticals Europe (Holland) and Teva Pharmaceutical Industries Ltd. (Israel) as Corporate Parent of Teva Pharmaceuticals USA, Inc. (els) (Entered: 01/16/2007)

Entry #3 • 2007-01-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,600,073 B1; 6,500,987 B1; 6,495,721 B1; 6,897,340 B2; (els) (Entered: 01/16/2007)

Entry #4 • 2007-01-16
1
Court Order

MOTION for Discovery of Process Information-Expedited - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Text of Proposed Order)(Ingersoll, Josy) (Entered: 01/29/2007)

Entry #5 • 2007-01-29
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc